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Tamaka Swasa or bronchial asthma is disease in 
which the process of respiration is disturbed. 
Breathlessness is one of the cardinal symptoms in this 
disease. It is more physiological disorder, so 
physiology of respiration is important to understand. 
In the context for the diagnostic aspect, clinically with 
the stethoscope or by the spirometry technique, the 
normal physiology is important. when the Prana Vayu 
is not  performing  its  normal  physiological  functions 
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(vitiated) and become defiles (Viguna); obstructed by 
Kapha and moves upwards i.e., unable to function 
properly, then the condition is known as Swasa Roga. 
This definition seems to be very scientific and 
describes all the aspects of dyspnoea. The 
classification of Swasa is based on the type of rhythm 
of respiration, which is cardinal symptoms, and to 
differentiate of severity from each other. 
OBJECTIVE 
To evaluate the efficacy of Vamana and Virechana in 
Tamaka Swasa. 
MATERIALS AND METHODS 
Clinical data: Minimum 30 diagnosed patients of 
Tamaka Swasa were taken for study from OPD and 
IPD of Vaidya Vagya Dutta Sharma Ayurvedic Post 
Graduate Mahavidalaya, Khurja, Uttar Pradesh from 
other camps and Referrals. 
Sample size and grouping 
Group A - Vamana Karma (15 patient), Group B - 
Virechana Karma (15 patient). 
A B S T R A C T  
In Tamaka Swasa there is condition of (1) Yapyatva (palliative) and (2) Chirakaritva (chronic) and (3) 
more Kshaya of Rasha Dhatus (decrease in the immunity) in this condition, the patient need a special 
type of management which can combated above three condition. Tamaka Swasa which is compared 
with Bronchial Asthma is a common problem and its prevalence is in all age groups irrespective of sex. 
Among five types of Swasa Roga, Tamaka Swasa is one of the most common and very well explained 
in Ayurvedic classics which can be compared with asthma in modern science. Mortality due to asthma 
is not comparable in size to the day today effect of the disease. Although largely avoidable, asthma 
tends to occur in epidemics and effect young people. The human and economic burden associated with 
this condition is severe. The study is carried out as a comparative study of Vamana  and  Virechana. 
In this Group (Group–A), Vamana was given to the patients. Total 15 patients were registered. In this 
Group (Group–B), patients were taken for Virechana. Total 15 patients were registered. 
Key words: Tamaka Swasa, Broncial Asthama, Vamana, Virechana. 
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Diagonstic Criteria 
Diagnosis was established by clinical examination and 
sign and symptoms of Tamaka Swasa as follows: 
1. Swasakrichrata (Breathlessness) 
2. Tamo Darshanam 
3. Kasa (cough) 
4. Trishna 
Criteria for the assessment of overall effect of the 
therapies 
The total effect of the therapy was assessed 
considering to the over all improvement in signs and 
symptoms. For this purpose, following categories 
were maintained.  
1. Complete remission: 100% relief in the signs and 
symptoms were considered as complete 
remission.  
2. Marked improvement: 75%- 99% relief in the 
signs and symptoms were considered as markedly 
improvement.  
3. Moderate Improvement: 50%- 74% relief in the 
signs and symptoms were considered as 
moderate. 
4. Mild Improvement: 25%- 49% relief in the signs 
and symptoms were considered as mild 
improvement.  
5. Unchanged: Below 0%-24% relief in the signs and 
symptoms were considered as unchanged. 
OBSERVATIONS 
Out of 30 patients, maximum 33.3% patients were of 
56-65 yrs age group and followed by 30% of 50-55 yrs 
group, 19 (63.3%) were female and 11 (36.7%) 
patients were male. maximum patients 24 (80%) were 
Hindu, 05 (16.7%) were Muslim and 01 (3.3%) was 
Christian, All 30 (100%) patients were married, 
maximum 21 (70%) patients were not having any 
habits, 08 (26.7%) patients had habit of intake of 
alcohol and 01 (3.3%) having tobacco taking habit. 
Maximum 19 (63.3%) patients were of moderate work 
class, 10 (33.3%) patients were of active work class 
and 01 (3.3%) patients were of sedentary work class. 
Maximum 20 (66.7%) patients belonged to 45-65 kgs 
class, 06 (20%) belonged to 65-85 kgs class and 04 
(13.3%) to 25-45 kgs class. Maximum 14 (46.7%) 
patients were of lower middle class, 12 (40%) patients 
were of upper middle class and 04 (13.3%) patients 
were of Lower class. Maximum 21 (70%) patients 
were of mixed diet and 09 (30%) were vegetarian. 
Maximum 17 (56.6%) patients were having good 
appetite, 11 (36.7%) patients were having moderate 
appetite and 02 (6.7%) patients were having poor 
appetite. Maximum 16 (53.3%) patients were having 
Chronicity upto 1 year, 12 (40% ) patients were of 1-2 
year and 02 (6.7%) were of more than 2 year 
chronicity. Maximum 29 (96.7%) patients bowel habit 
were regular. 
RESULTS 
Statistical analysis of group A showed that the mean 
score of  Swasakrichrata, which was 1.93 before the 
treatment was  reduced  to 1.2  after treatment  with 
37.93% improvement with p value <0.001, it is 
statistically significant. Statistical analysis of group B 
showed that the mean score of  Swasakrichrata, 
which was 2.33  before the treatment was  reduced to 
1.33  after treatment  with 42.85% improvement with 
p value <0.001, it is statistically significant. 
Statistical analysis of group A showed that the mean 
score of  Kasa, which was 1.93 before the treatment 
was  reduced  to 1.06  after treatment  with  44.82% 
improvement with p value <0.001, it is statistically 
significant. Statistical analysis of group B showed that 
the mean score of  Kasa,  which was  2.53 before the 
treatment was  reduced to 1.13  after treatment  with  
55.26% improvement with p value <0.001, it is 
statistically significant. 
Statistical analysis of group A showed that the mean 
score of  Kapha Nisteevana, which was 2.8 before the 
treatment was  reduced to 1.46  after treatment  with  
47.61% improvement with p value <0.001, it is 
statistically significant. Statistical analysis of group B 
showed that the mean score of  Kapha Nisteevana, 
which was  2.8 before the treatment was  reduced to 
1.06 after treatment  with  61.9% improvement with p 
value <0.001, it is statistically significant. 
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Statistical analysis of group A showed that the mean 
score of Anidra,  which was 2.46 before the treatment 
was  reduced  to 1.6  after treatment  with 35.13 % 
improvement with p value <0.001, it is statistically 
significant. Statistical analysis of group B showed that 
the mean score of Anidra,  which was 2.46  before the 
treatment was  reduced to 1  after treatment  with  





Table 1: Showing the comparative results of Group - 
A and Group - B 
Characteris
tics 
































Kapha 2.8 1.4 47.61% 2.8 1.0 61.9% 







Discussion is the most among all in increasing 
intellect. Here, the study is done on Tamaka Swasa; it 
is a disease of multi factorial causation where effect of 
nature, diet i.e., Aahara and Vihara plays an 
important role. In the management of this disease all 
the factors are taken in consideration. It is a disease of 
Pranavaha Srotas with the vitiation of Kapha and Vata 
Dosha and origin in Pittasthana. This study was 
carried out in two groups. Each of group will contain 
15 patients. Comparative study between two drugs 
was carried by giving Vamana to one group and 
Virechana to second group. Result of group A 
(Vamana with Pippali Churna and Yastimadhu 
Phanta). The percentage of improvement in group A 
on the Swasakrichrata  is  37.93%, Kasa is  44.82%, 
Kapha Nisteevana  is 47.61%,  and  Anidra  is 35.13%. 
Result of group B (Virechana with Trivrit Churna, 
Triphala and Danti). The percentage of improvement 
in group B on the Swasakrichrata is 42.85%, Kasa is  
55.26%, Kapha Nisteevana is 61.9%, and Anidra  is 
59.45%. Overall result or group A is 41.37%, overall 
result or group B is 54.86%.  
Proble mode of action of Virechana in Tamaka 
Shwasa 
The site of origin of Shwasa Roga is Pittasthana. 
Virechana Karma is indicated as the best treatment 
for the aggravated Pitta Dosha. Therefore, Virechana 
helps in maintaining the normal levels of Pitta Dosha. 
Acharya Charaka also mentioned ‘Tamketu 
Virechanam’. If Vata Dosha remains associated with 
other Doshas, then Mridu Virechana should be done. 
Virechana Karma pacifies Vata Dosha which is 
associated with Kapha in patients of Shvasa Roga. So 
the patients got relief by Virechana , in the present 
study. 
CONCLUSION 
Tamaka Shwasa is one among 5 types of Shwasa 
Roga, that is Kshudra Shwasa, Chinna Shwasa, 
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Mahashwasa, Urdhva Shwasa. Tamaka Shwasa 
affects the Pranavaha Strotas and characterised by 
prolonged expiration, wheeze, dyspnoea of 
exceedingly deep velocity, which is immense injurious 
to life. Vata moving  in reverse direction prevades the 
channels, afflicts the neck and head, and stimulates 
Kapha to cause Margavrodha  by producing broncho 
constriction. Tamaka Shwasa classifies as Vata 
Pradhana and Kapha Pradhana. Sign and symptoms of 
Tamaka Shwasa are very much similar to that of 
bronchial asthma. In the present study it is observed 
that the age group above 40 years of age is more 
affected by the disease  and patients having 
addictions of smoking and chewing tobbaco are more 
affected from the disease. Pollution affects the 
patients more vigorously, is observed in the study. In 
present study following symptoms were taken into 
consideration, Shwasa Krichata, Kasa, Anidra, 
Kaphanisteevana. Both the procedures Vamana and 
Virechana helps the patients in relieving the 
symptoms. As extra Kapha is removed by Vamana, 
and as the Sthana of the disease is Pittaudhbhava, so 
Pitta is relieved by Virechana, so Virechana also helps 
in relieving the symptoms of Tamaka Shwasa. 
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